Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Jelena Martinovic

Flora Growth's New CBD Formulation To Prevent Infection From COVID 19, Pending Regulatory Approval To Launch Clinical Trials

Cannabis producer Flora Growth Corp. (NASDAQ:FLGC) announced today that its seeking approval from INVIMA, the Colombian FDA, to begin research on their patent-pending, cannabinoid-based product, citing recent studies stating the possibility of cannabinoids to display viral inhibition.

The study will be conducted through Flora’s research division, Flora Pharma, with formulation taking place in its GMP-certified Colombian lab.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.